Effect of case management on unmet needs and utilization of medical care and medications among HIV-infected persons

Annals of Internal Medicine

Volumn 135, Issue 8 II, 2001, Pages 557-565

  Katz, M H ^a   Cunningham, W E ^a   Fleishman, J A ^a   Andersen, R M ^a   Kellogg, T ^a   Bozzette, S A ^a   Shapiro, M F ^a  

^a Department of Public Health ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DRUG USE; EMERGENCY TREATMENT; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT COUNSELING; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; TOXOPLASMOSIS;

EID: 0035899936     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-135-8_part_1-200110160-00006     Document Type: Article

References (32)

1. Case-managing AIDS
2. AIDS case management: The client's perspective
3. Community-based case management for persons with AIDS
4. Evaluation of HIV case management services: An overview
5. A review of systematic data analysis toward the effectiveness of HIV case management
6. HIV-infected client care: Case management and the HIV team
7. Case management in a community-based AIDS agency
8. Support service use by persons with AIDS and their caregivers
9. The integration of informal care, case management and community-based services for persons with HIV/AIDS
10. Prevalence and predictors of unmet need for supportive services among HIV-infected persons: Impact of case management
11. HIV case management services in New York City: Quality and outcomes
12. Evaluation of an innovative program to address the health and social service needs of drug-using women with or at risk for HIV infection
13. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration
14. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
15. Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis
16. Impact of protease inhibitors and other antiretroviral treatments on AIDS survival in San Francisco, 1987-1996
17. National probability samples in studies of low-prevalence diseases. Part I: Perspectives and lessons from the HIV cost and services utilization study
18. National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample
19. Repeated emergency department use by HIV-infected persons: Effect of clinic accessibility and expertise in HIV care
20. Revisiting the behavioral model and access to medical care: Does it matter?
21. Inference from complex samples
22. Human immunodeficiency virus 1 protease inhibitors in clinical practice: Predictors of virological outcome
23. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions
24. Protease inhibitor use among a community sample of people with HIV disease
25. Variations in the care of HIV-infected adults in the United States: Results from the HIV Cost and Services Utilization Study
26. Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study
27. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure
28. Reliability and validity of self-report CD4 counts-in persons hospitalized with HIV disease